Blood Lead Levels in Opium-Poisoned Children: One Cross-Sectional Study in Iran

Arezoo Chouhdari1, Fariba Farnaghi2, Hossein Hassanian-Moghaddam3

  • 1Skull Base Research Center, Loghman Hakim Hospital AND Department of Health and Community Medicine, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Addiction & Health
|November 27, 2020
PubMed

Insights

Opium poisoning in children can lead to elevated blood lead levels (BLLs), particularly in girls. Further research is needed to understand the correlation between BLLs and hemoglobin levels in affected children.

Area of Science:

  • Pediatric Toxicology
  • Environmental Health
  • Public Health

Background:

  • Lead poisoning is an increasing concern, often linked to opium exposure.
  • Understanding the impact of lead on children's health is critical.

Purpose of the Study:

  • To investigate the relationship between blood lead levels (BLLs) and demographic factors in children with opium poisoning.
  • To assess the prevalence of elevated BLLs in this vulnerable population.

Main Methods:

  • A cross-sectional study involving 32 children under 13 years old admitted for opium poisoning.
  • Evaluation of BLLs, demographics, clinical signs, and laboratory tests.

Main Results:

  • The mean BLL was 9.78 ± 3.44 μg/dl, with 70% of children having BLLs ≥ 5 μg/dl.
  • Girls exhibited significantly higher mean BLLs (17.07 ± 6.57 μg/dl) compared to boys (6.61 ± 3.22 μg/dl).
  • A significant correlation was observed between BLLs and hemoglobin levels, with a complex relationship at different Hb concentrations.

Conclusions:

  • Preventive strategies are essential to protect children from lead exposure via opium and other contaminated materials.
  • While chelation therapy wasn't required, the long-term effects of lead exposure on children's organs warrant attention.
Abstract

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.3K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
87
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
121
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
93
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
854